{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05380349",
            "orgStudyIdInfo": {
                "id": "161581"
            },
            "organization": {
                "fullName": "Swedish Medical Center",
                "class": "OTHER"
            },
            "briefTitle": "Personalized Cancer Stem Cell High-Throughput Drug Screening for Glioblastoma",
            "officialTitle": "A Phase 1 Study of Combination Drug Therapy Based on Personalized Cancer Stem Cell (CSC) High-Throughput Drug Screening (HTS) With Standard of Care for Newly Diagnosed Glioblastoma",
            "therapeuticArea": [
                "Other"
            ],
            "study": "personalized-cancer-stem-cell-high-throughput-drug-screening-for-glioblastoma"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-05",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-04-19",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2026-12",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2027-12",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2022-04-21",
            "studyFirstSubmitQcDate": "2022-05-17",
            "studyFirstPostDateStruct": {
                "date": "2022-05-18",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-05-07",
            "lastUpdatePostDateStruct": {
                "date": "2024-05-08",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Swedish Medical Center",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "Proposed treatment of subjects with newly diagnosed glioblastoma with novel personalized drug regimens identified to be effective in vitro using cancer stem cells derived from their individual tumors, alongside standard of care radiation and TMZ.",
            "detailedDescription": "A panel of FDA approved drugs will be tested by high throughput screening, which is CLIA certified allowing for clinical decisions based on the results, to identify a combination of up to 3 drug candidates for treating individual patients. Lead candidates will be evaluated by pharmacists and a team of physicians, to confirm that prescribed drugs do not utilize pharmacological/ metabolic pathways that are known to increase the likelihood of toxicity, prior to initiating treatment. Investigational drug therapy, targeting CSCs, will be initiated alongside standard of care chemoradiation with TMZ."
        },
        "conditionsModule": {
            "conditions": [
                "Newly Diagnosed Glioblastoma"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "EARLY_PHASE1"
            ],
            "designInfo": {
                "allocation": "NA",
                "interventionModel": "SEQUENTIAL",
                "interventionModelDescription": "single-center Phase 1 open-label study",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 10,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Personalized Combination Drug Therapy for Cancer Stem Cells",
                    "type": "EXPERIMENTAL",
                    "description": "Administer combinations of up to 3 FDA approved drugs from a panel of compounds selected based on high throughput screening",
                    "interventionNames": [
                        "Drug: combinations of up to 3 FDA approved drugs from a panel of compounds"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "combinations of up to 3 FDA approved drugs from a panel of compounds",
                    "description": "personalized drug combinations",
                    "armGroupLabels": [
                        "Personalized Combination Drug Therapy for Cancer Stem Cells"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "determine safety of CSC/HTS-based combination drug therapy",
                    "description": "incidence of treatment-related AEs, laboratory abnormalities, and SAEs as assessed by CTCAE version 5.0",
                    "timeFrame": "From date of first dose of investigational drug regimen until date of first documented progression or death from any cause, whichever came first, assessed up to 24 months."
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Efficacy of CSC/HTS-based combination drug therapy",
                    "description": "Response assessment per Response Assessment in Neuro-Oncology (RANO) criteria",
                    "timeFrame": "From inclusion in the study up to approximately 36 months"
                },
                {
                    "measure": "Efficacy of CSC/HTS-based combination drug therapy",
                    "description": "Progression-free survival (PFS)",
                    "timeFrame": "From inclusion in the study until the date of first documented progression or date of death from any cause, whichever came first, assessed up to approximately 36 months"
                },
                {
                    "measure": "Efficacy of CSC/HTS-based combination drug therapy",
                    "description": "Median overall survival (OS)",
                    "timeFrame": "From inclusion in the study until date of death from any cause, assessed up to approximately 36 months"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Histological diagnosis of GBM (WHO grade 4)\n* Subjects \u226518 years of age\n* Patients must have a life expectancy of \\>6 months\n* Patients must have a surgically accessible tumor with the intent for a gross or near total resection of the tumor mass (GBM, WHO grade 4)\n* Patients must have a KPS rating of \u226570\n* Patients should not have received any prior systemic anti-cancer therapy\n* Patients must be negative for HIV, Hepatitis B and C\n* Baseline hematologic studies and chemistry and coagulation profiles must meet the following criteria:\n\n  * Hemoglobin (Hgb)\\> 8 g/dL\n  * Absolute Neutrophil Count (ANC) \\> 1,000/mm3\n  * Platelet count \\> 100,000/mm3\n  * Creatinine \\< 2 mg/dL\n  * Alkaline Phosphatase (ALP), Aspartate Aminotransferase (AST) and Alanine Aminotransferase (ALT) \\< 3x upper limit of normal (ULN)\n\nExclusion Criteria:\n\n* Metastatic disease\n* Diseases or conditions that obscure toxicity or dangerously alter drug metabolism\n* Serious intercurrent medical illness\n* Inadequately controlled hypertension\n* History of myocardial infarction or unstable angina within 6 months\n* History of stroke or transient ischemic attack within 6 months",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Charles S Cobbs, M.D.",
                    "role": "CONTACT",
                    "phone": "206-320-2300",
                    "email": "charles.cobbs@swedish.org"
                },
                {
                    "name": "Parvinder Hothi, Ph.D.",
                    "role": "CONTACT",
                    "phone": "206-320-3145",
                    "email": "parvinder.hothi@swedish.org"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Charles S Cobbs",
                    "affiliation": "Ivy Center for Advanced Brain Tumor Treatment",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Swedish Medical Center",
                    "status": "RECRUITING",
                    "city": "Seattle",
                    "state": "Washington",
                    "zip": "98122",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Nathan Hansen",
                            "role": "CONTACT",
                            "phone": "206-320-3542",
                            "email": "nathan.hansen@swedish.org"
                        }
                    ],
                    "geoPoint": {
                        "lat": 47.60621,
                        "lon": -122.33207
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000005909",
                    "term": "Glioblastoma"
                }
            ],
            "ancestors": [
                {
                    "id": "D000001254",
                    "term": "Astrocytoma"
                },
                {
                    "id": "D000005910",
                    "term": "Glioma"
                },
                {
                    "id": "D000018302",
                    "term": "Neoplasms, Neuroepithelial"
                },
                {
                    "id": "D000017599",
                    "term": "Neuroectodermal Tumors"
                },
                {
                    "id": "D000009373",
                    "term": "Neoplasms, Germ Cell and Embryonal"
                },
                {
                    "id": "D000009370",
                    "term": "Neoplasms by Histologic Type"
                },
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000009375",
                    "term": "Neoplasms, Glandular and Epithelial"
                },
                {
                    "id": "D000009380",
                    "term": "Neoplasms, Nerve Tissue"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M9019",
                    "name": "Glioblastoma",
                    "asFound": "Glioblastoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4561",
                    "name": "Astrocytoma",
                    "relevance": "LOW"
                },
                {
                    "id": "M9020",
                    "name": "Glioma",
                    "relevance": "LOW"
                },
                {
                    "id": "M20446",
                    "name": "Neoplasms, Neuroepithelial",
                    "relevance": "LOW"
                },
                {
                    "id": "M19845",
                    "name": "Neuroectodermal Tumors",
                    "relevance": "LOW"
                },
                {
                    "id": "M20388",
                    "name": "Neuroectodermal Tumors, Primitive",
                    "relevance": "LOW"
                },
                {
                    "id": "M12318",
                    "name": "Neoplasms, Germ Cell and Embryonal",
                    "relevance": "LOW"
                },
                {
                    "id": "M12315",
                    "name": "Neoplasms by Histologic Type",
                    "relevance": "LOW"
                },
                {
                    "id": "M12320",
                    "name": "Neoplasms, Glandular and Epithelial",
                    "relevance": "LOW"
                },
                {
                    "id": "M12325",
                    "name": "Neoplasms, Nerve Tissue",
                    "relevance": "LOW"
                },
                {
                    "id": "T2518",
                    "name": "Glioblastoma",
                    "asFound": "Glioblastoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "T2519",
                    "name": "Glioma",
                    "relevance": "LOW"
                },
                {
                    "id": "T4092",
                    "name": "Neuroepithelioma",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        }
    },
    "hasResults": false
}